143 related articles for article (PubMed ID: 36842454)
1. Inhibition by pesticides of the DJ-1/Park7 protein related to Parkinson disease.
Mathas N; Poncet G; Laurent C; Larigot L; Le-Grand B; Gonis E; Birman S; Galardon E; Sari MA; Tiouaini M; Nioche P; Barouki R; Coumoul X; Mansuy D; Dairou J
Toxicology; 2023 Mar; 487():153467. PubMed ID: 36842454
[TBL] [Abstract][Full Text] [Related]
2. PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target.
Lind-Holm Mogensen F; Scafidi A; Poli A; Michelucci A
J Neuroinflammation; 2023 Apr; 20(1):95. PubMed ID: 37072827
[TBL] [Abstract][Full Text] [Related]
3. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
Pap D; Veres-Székely A; Szebeni B; Vannay Á
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743072
[TBL] [Abstract][Full Text] [Related]
4. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
5. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
Hijioka M; Inden M; Yanagisawa D; Kitamura Y
Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
[TBL] [Abstract][Full Text] [Related]
6. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.
Guo T; Zhou L; Xiong M; Xiong J; Huang J; Li Y; Zhang G; Chen G; Wang ZH; Xiao T; Hu D; Bao A; Zhang Z
Aging Cell; 2024 May; 23(5):e14124. PubMed ID: 38380563
[TBL] [Abstract][Full Text] [Related]
7. Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson's Disease.
Vázquez-Mayorga E; Díaz-Sánchez ÁG; Dagda RK; Domínguez-Solís CA; Dagda RY; Coronado-Ramírez CK; Martínez-Martínez A
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556455
[TBL] [Abstract][Full Text] [Related]
8. Expression of DJ-1 in Neurodegenerative Disorders.
Antipova D; Bandopadhyay R
Adv Exp Med Biol; 2017; 1037():25-43. PubMed ID: 29147901
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite.
Heremans IP; Caligiore F; Gerin I; Bury M; Lutz M; Graff J; Stroobant V; Vertommen D; Teleman AA; Van Schaftingen E; Bommer GT
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046029
[TBL] [Abstract][Full Text] [Related]
10. Progressive Motor and Non-Motor Symptoms in
Chavali LNM; Yddal I; Bifulco E; Mannsåker S; Røise D; Law JO; Frøyset AK; Grellscheid SN; Fladmark KE
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047429
[TBL] [Abstract][Full Text] [Related]
11. DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology.
Taipa R; Pereira C; Reis I; Alonso I; Bastos-Lima A; Melo-Pires M; Magalhães M
Brain; 2016 Jun; 139(Pt 6):1680-7. PubMed ID: 27085187
[TBL] [Abstract][Full Text] [Related]
12. Kinetic evidence in favor of glyoxalase III and against deglycase activity of DJ-1.
Choi J; Tak S; Jung HM; Cha S; Hwang E; Lee D; Lee JH; Ryu KS; Park C
Protein Sci; 2023 May; 32(5):e4641. PubMed ID: 37060572
[TBL] [Abstract][Full Text] [Related]
13. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
14. The Tale of DJ-1 (PARK7): A Swiss Army Knife in Biomedical and Psychological Research.
Sun ME; Zheng Q
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108572
[TBL] [Abstract][Full Text] [Related]
15. The apparent deglycase activity of DJ-1 results from the conversion of free methylglyoxal present in fast equilibrium with hemithioacetals and hemiaminals.
Andreeva A; Bekkhozhin Z; Omertassova N; Baizhumanov T; Yeltay G; Akhmetali M; Toibazar D; Utepbergenov D
J Biol Chem; 2019 Dec; 294(49):18863-18872. PubMed ID: 31653696
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation.
Li L; Si X; Lei M; Yang J; Ruan J; Liu H; Huang F; Jin X; Xie K; Yang H; Lei X; Liu Y
Stem Cell Res; 2023 Feb; 66():102983. PubMed ID: 36469984
[TBL] [Abstract][Full Text] [Related]
17. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
Dolgacheva LP; Berezhnov AV; Fedotova EI; Zinchenko VP; Abramov AY
J Bioenerg Biomembr; 2019 Jun; 51(3):175-188. PubMed ID: 31054074
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease-related DJ-1 functions in thiol quality control against aldehyde attack in vitro.
Matsuda N; Kimura M; Queliconi BB; Kojima W; Mishima M; Takagi K; Koyano F; Yamano K; Mizushima T; Ito Y; Tanaka K
Sci Rep; 2017 Oct; 7(1):12816. PubMed ID: 28993701
[TBL] [Abstract][Full Text] [Related]
19. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
[TBL] [Abstract][Full Text] [Related]
20. Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism.
Olivo E; La Chimia M; Ceramella J; Catalano A; Chiaradonna F; Sinicropi MS; Cuda G; Iacopetta D; Scumaci D
Cells; 2022 Apr; 11(9):. PubMed ID: 35563738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
